Search Results - "GRIMSBY, JOSEPH"
-
1
The dynamic plasticity of insulin production in β-cells
Published in Molecular metabolism (Germany) (01-09-2017)“…Abstract Background Although the insulin-producing pancreatic β-cells are quite capable of adapting to both acute and chronic changes in metabolic demand,…”
Get full text
Journal Article -
2
BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis
Published in Diabetes (New York, N.Y.) (01-05-2015)“…The limited expandability of subcutaneous adipose tissue, due to reduced ability to recruit and differentiate new adipocytes, prevents its buffering effect in…”
Get full text
Journal Article -
3
Differences in levels of phosphatidylinositols in healthy and stable Coronary Artery Disease subjects revealed by HILIC-MRM method with SERRF normalization
Published in PloS one (04-06-2021)“…Quantification of endogenous biomarkers in clinical studies requires careful evaluation of a number of assay performance parameters. Comparisons of absolute…”
Get full text
Journal Article -
4
Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice
Published in Molecular & cellular proteomics (01-06-2020)“…An unbiased quantitative profiling of the protein expression, phosphorylation, and sialylation events that occur upon β-cell adaptive flexibility during the…”
Get full text
Journal Article -
5
Proteomic Analysis of Restored Insulin Production and Trafficking in Obese Diabetic Mouse Pancreatic Islets Following Euglycemia
Published in Journal of proteome research (06-09-2019)“…For the treatment of patients with prediabetes or diabetes, clinical evidence has emerged that β-cell function can be restored by glucose-lowering therapeutic…”
Get full text
Journal Article -
6
β-Cell Control of Insulin Production During Starvation-Refeeding in Male Rats
Published in Endocrinology (Philadelphia) (01-02-2018)“…Abstract Mammalian metabolism has evolved to adapt to changes in nutrient status. Insulin, the key anabolic hormone, facilitates intracellular storage of…”
Get full text
Journal Article -
7
The prevalence of low muscle mass associated with obesity in the USA
Published in Skeletal muscle (21-12-2022)“…Sarcopenia is defined as age-related low muscle mass and function, and can also describe the loss of muscle mass in certain medical conditions, such as…”
Get full text
Journal Article -
8
Pancreatic β-Cell Rest Replenishes Insulin Secretory Capacity and Attenuates Diabetes in an Extreme Model of Obese Type 2 Diabetes
Published in Diabetes (New York, N.Y.) (01-01-2019)“…The onset of common obesity-linked type 2 diabetes (T2D) is marked by exhaustive failure of pancreatic β-cell functional mass to compensate for insulin…”
Get full text
Journal Article -
9
1200-P: The Prevalence of Obesity-Associated Loss of Lean Muscle Mass
Published in Diabetes (New York, N.Y.) (01-06-2022)“…Sarcopenia, originally defined as age-related low muscle mass and function, has also been used to describe the loss of muscle mass and quality among certain…”
Get full text
Journal Article -
10
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis
Published in Nature metabolism (01-05-2020)“…Non-alcoholic fatty liver disease and steatohepatitis are highly associated with obesity and type 2 diabetes mellitus. Cotadutide, a glucagon-like protein-1…”
Get full text
Journal Article -
11
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease
Published in Scientific reports (18-11-2021)“…Peptide therapeutics are increasingly used in the treatment of disease, but their administration by injection reduces patient compliance and convenience,…”
Get full text
Journal Article -
12
A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
Published in Hepatology (Baltimore, Md.) (01-03-2017)“…Because nonalcoholic steatohepatitis (NASH) is associated with impaired liver regeneration, we investigated the effects of G49, a dual glucagon‐like…”
Get full text
Journal Article -
13
Pancreatic Beta Cells in Very Old Mice Retain Capacity for Compensatory Proliferation
Published in The Journal of biological chemistry (10-08-2012)“…Recent studies suggested that in old mice, beta cells lose their regenerative potential and cannot respond to mitogenic triggers. These studies examined beta…”
Get full text
Journal Article -
14
High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control
Published in Nature communications (29-11-2021)“…To improve the power of mediation in high-throughput studies, here we introduce High-throughput mediation analysis (Hitman), which accounts for direction of…”
Get full text
Journal Article -
15
LOX-1: A potential driver of cardiovascular risk in SLE patients
Published in PloS one (17-03-2020)“…Traditional cardiovascular disease (CVD) risk factors, such as hypertension, dyslipidemia and diabetes do not explain the increased CVD burden in systemic…”
Get full text
Journal Article -
16
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial
Published in Science translational medicine (21-04-2021)“…Cardiovascular disease (CVD) is the leading global cause of death, and treatments that further reduce CV risk remain an unmet medical need. Epidemiological…”
Get more information
Journal Article -
17
The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy
Published in Diabetes (New York, N.Y.) (01-01-2006)“…The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy Franz M. Matschinsky 1 ,…”
Get full text
Journal Article -
18
Discovery of PiragliatinFirst Glucokinase Activator Studied in Type 2 Diabetic Patients
Published in Journal of medicinal chemistry (23-08-2012)“…Glucokinase (GK) activation as a potential strategy to treat type 2 diabetes (T2D) is well recognized. Compound 1, a glucokinase activator (GKA) lead that we…”
Get full text
Journal Article -
19
Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating Mutations
Published in Diabetes (New York, N.Y.) (01-06-2009)“…Extremes of Clinical and Enzymatic Phenotypes in Children With Hyperinsulinism Caused by Glucokinase Activating Mutations Samir Sayed 1 , David R. Langdon 2 ,…”
Get full text
Journal Article -
20
Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics
Published in American journal of physiology: endocrinology and metabolism (01-01-2012)“…It was reported previously that isolated human islets from individuals with type 2 diabetes mellitus (T2DM) show reduced glucose-stimulated insulin release. To…”
Get more information
Journal Article